KR102440039B9 - 흡입전달용 핵산 또는 단백질 탑재 폐 계면활성제입자 및 이의 제조 방법 - Google Patents

흡입전달용 핵산 또는 단백질 탑재 폐 계면활성제입자 및 이의 제조 방법

Info

Publication number
KR102440039B9
KR102440039B9 KR1020210016442A KR20210016442A KR102440039B9 KR 102440039 B9 KR102440039 B9 KR 102440039B9 KR 1020210016442 A KR1020210016442 A KR 1020210016442A KR 20210016442 A KR20210016442 A KR 20210016442A KR 102440039 B9 KR102440039 B9 KR 102440039B9
Authority
KR
South Korea
Prior art keywords
protein
loaded
manufacturing
nucleic acid
pulmonary surfactant
Prior art date
Application number
KR1020210016442A
Other languages
English (en)
Other versions
KR20210100032A (ko
KR102440039B1 (ko
Inventor
박지호
오찬희
Original Assignee
한국과학기술원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국과학기술원 filed Critical 한국과학기술원
Publication of KR20210100032A publication Critical patent/KR20210100032A/ko
Application granted granted Critical
Publication of KR102440039B1 publication Critical patent/KR102440039B1/ko
Publication of KR102440039B9 publication Critical patent/KR102440039B9/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
KR1020210016442A 2020-02-05 2021-02-05 흡입전달용 핵산 또는 단백질 탑재 폐 계면활성제입자 및 이의 제조 방법 KR102440039B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020200013867 2020-02-05
KR20200013867 2020-02-05

Publications (3)

Publication Number Publication Date
KR20210100032A KR20210100032A (ko) 2021-08-13
KR102440039B1 KR102440039B1 (ko) 2022-09-05
KR102440039B9 true KR102440039B9 (ko) 2023-03-23

Family

ID=77200771

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210016442A KR102440039B1 (ko) 2020-02-05 2021-02-05 흡입전달용 핵산 또는 단백질 탑재 폐 계면활성제입자 및 이의 제조 방법

Country Status (8)

Country Link
US (1) US20230092682A1 (ko)
EP (1) EP4085900A4 (ko)
JP (1) JP2023513132A (ko)
KR (1) KR102440039B1 (ko)
CN (1) CN115052585A (ko)
AU (1) AU2021215673A1 (ko)
CA (1) CA3165626A1 (ko)
WO (1) WO2021158053A1 (ko)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046273A2 (en) * 1997-04-17 1998-10-22 Paola Leone Delivery system for gene therapy to the brain
JP2001002592A (ja) * 1999-06-18 2001-01-09 Dai Ichi Seiyaku Co Ltd 遺伝子導入用組成物
JP2003012503A (ja) * 2001-06-22 2003-01-15 Techno Network Shikoku Co Ltd 脂質ベシクルおよび遺伝子を固定化する方法
US20100284969A1 (en) * 2007-06-05 2010-11-11 Frank Guarnieri Methods and Compositions for Delivery of Medicaments to the Lungs
TW201208690A (en) * 2010-08-05 2012-03-01 Indian Inst Of Technology Iit Bombay Lipid formulations
CN103550783A (zh) * 2013-04-27 2014-02-05 中国人民解放军军事医学科学院放射与辐射医学研究所 一种核酸类药物靶向递送系统及其制备方法
CN112135604A (zh) * 2018-05-18 2020-12-25 韩国科学技术院 基于肺表面活性物质的抗癌药物

Also Published As

Publication number Publication date
KR20210100032A (ko) 2021-08-13
EP4085900A4 (en) 2023-07-26
US20230092682A1 (en) 2023-03-23
WO2021158053A1 (ko) 2021-08-12
AU2021215673A1 (en) 2022-09-08
CN115052585A (zh) 2022-09-13
JP2023513132A (ja) 2023-03-30
EP4085900A1 (en) 2022-11-09
CA3165626A1 (en) 2021-08-12
KR102440039B1 (ko) 2022-09-05

Similar Documents

Publication Publication Date Title
IL286424A (en) A method for the preparation of lipid-warmed RNA nanoparticles
WO2017127807A8 (en) Crystal structure of crispr cpf1
IL265598A (en) Enzymes that modify RNA-directed nucleic acids and methods for using them
IL265599A (en) RNA-directed amino acid-modifying enzymes and methods of using them
WO2016205749A8 (en) Novel crispr enzymes and systems
EP3009511A3 (en) Novel crispr enzymes and systems
PL3618811T3 (pl) Proces wytwarzania porowatych cząsteczek krzemionki załadowanych co najmniej jednym związkiem bioaktywnym dostosowanych do dostarczania dopłucnego, donosowego, podjęzykowego i/lub dogardłowego
WO2007106683A3 (en) Biomimetic iron-oxide-containing lipoprotein and related materials
GB2492167B (en) Structured particles
WO2003072720A3 (en) Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
WO2016183366A3 (en) Compositions and methods for silencing expression of hepatitis d virus rna
AP2014007389A0 (en) Method of controlling the corrosion rate of alloy particles, alloy particle with controlled corrosionrate, and articles comprising the particle
IL260800B (en) A test tube for shaking using spheres and a method for extracting deoxyribonucleic acid and/or ribonucleic acid from microorganisms
WO2009117134A3 (en) Aerosolized genetic vaccines and methods of use
EP1939455A4 (en) WHEEL FOR MULTI-SHOVEL FANS AND MANUFACTURING METHOD THEREFOR
PT2954889T (pt) Composição para inalação que contém aclidínio para tratamento da doença pulmonar obstrutiva crónica
CO6361899A2 (es) Pariculas inhalables que comprenden tiotropio
KR102440039B9 (ko) 흡입전달용 핵산 또는 단백질 탑재 폐 계면활성제입자 및 이의 제조 방법
Dua et al. Targeting microRNAs using nanotechnology in pulmonary diseases.
EP3594269A4 (en) POLYLACTIC ACID PARTICLES AND THEIR MANUFACTURING PROCESS
WO2011094598A3 (en) Compositions and methods for reversing corticosteroid resistance or treating respiratory infections
PL3499610T3 (pl) Cząstki materiału czynnego elektrody dodatniej każda zawierająca rdzeń zawierający tlenek litu kobaltu oraz osłonę zawierającą fosforan litu kobaltu oraz sposób ich wytwarzania
BR112017023351A2 (pt) composições multidrogas de matriz frágil
SG11202111066UA (en) High density lipoprotein nanoparticles and rna templated lipoprotein particles for ocular therapy
IL189195A0 (en) A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma

Legal Events

Date Code Title Description
A302 Request for accelerated examination
E902 Notification of reason for refusal
E90F Notification of reason for final refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
G170 Re-publication after modification of scope of protection [patent]